NCT07769151

Brief Summary

The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
124

participants targeted

Target at P50-P75 for all trials

Timeline
64mo left

Started Sep 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Sep 2026Dec 2031

First Submitted

Initial submission to the registry

August 12, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 17, 2026

Completed
15 days until next milestone

Study Start

First participant enrolled

September 1, 2026

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2030

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2031

Last Updated

August 17, 2026

Status Verified

August 1, 2026

Enrollment Period

4.3 years

First QC Date

August 12, 2026

Last Update Submit

August 12, 2026

Conditions

Mortality Prediction

Outcome Measures

Primary Outcomes (1)

  • Non relapse mortality (NRM)

    NRM at day 100 and at year 1

Interventions

blood sample to check CXCL9 pre stem cell transplant and cell therapyDIAGNOSTIC_TEST

Pre SCTCT as per SOC physical function assessment will be performed in a form of IADl, hand grip, and or walk test like TUG. Specimen Collection Studies: LDH , albumin, ferritin, CRP, platelet and creatinine will be collected as per standard of care pre SCTCT. The non-SOC procedure will be drawing CXL9

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients \>18 year old planned for SCTCT

You may qualify if:

  • patients \>18 year old planned for SCTCT

You may not qualify if:

  • Pregnancy, prisoners , Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henry Ford Health

Detroit, Michigan, 48202, United States

RECRUITING

Central Study Contacts

Shatha Farhan, MD

CONTACT

3137133910sfarhan1@hfhs.org

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2026

First Posted

August 17, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

December 30, 2030

Study Completion (Estimated)

December 30, 2031

Last Updated

August 17, 2026

Record last verified: 2026-08

Locations

US(1)